TFS Capital’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-16,613
| Closed | -$53K | – | 439 |
|
|
2017
Q2 | $53K | Buy |
16,613
+1,813
| +12% | +$5.78K | 0.02% | 588 |
|
|
2017
Q1 | $42K | Sell |
14,800
-11,716
| -44% | -$33.2K | 0.01% | 633 |
|
|
2016
Q4 | $62K | Sell |
26,516
-66,083
| -71% | -$155K | 0.02% | 675 |
|
|
2016
Q3 | $156K | Buy |
+92,599
| New | +$156K | 0.04% | 595 |
|
|
2016
Q1 | – | Sell |
-17,642
| Closed | -$21K | – | 1134 |
|
|
2015
Q4 | $21K | Sell |
17,642
-122,000
| -87% | -$145K | ﹤0.01% | 727 |
|
|
2015
Q3 | $237K | Buy |
139,642
+25,212
| +22% | +$42.8K | 0.02% | 708 |
|
|
2015
Q2 | $238K | Buy |
114,430
+13,977
| +14% | +$29.1K | 0.02% | 717 |
|
|
2015
Q1 | $272K | Sell |
100,453
-22,965
| -19% | -$62.2K | 0.03% | 716 |
|
|
2014
Q4 | $317K | Sell |
123,418
-39,989
| -24% | -$103K | 0.03% | 713 |
|
|
2014
Q3 | $299K | Buy |
163,407
+118,521
| +264% | +$217K | 0.03% | 746 |
|
|
2014
Q2 | $120K | Buy |
+44,886
| New | +$120K | 0.01% | 1031 |
|